US Patent 7709228 Activatable recombinant neurotoxins
Patent 7709228 was granted and assigned to Allergan, Inc. on May, 2010 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7709228 Activatable recombinant neurotoxins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
